Some 20 weeks after stopping their drugs, the participants in the studies had put back on an average of 2.5 kilograms (5.5 ...

This discovery may lead to a novel treatment approach that targets underlying brain pressure mechanisms rather than just managing symptoms. The research suggests that liraglutide, a drug originally ...

Around five million Australians suffer from migraines, with women three times more likely to be affected than men ...

Over 12 weeks, 26 patients suffering frequent migraines and obesity received a daily dose of the GLP-1 agonist liraglutide. Remarkably, the average number of migraine days per month fell sharply ...

Weight loss jabs could cut the number of migraines sufferers experience by half, research suggests. The drugs, similar to Ozempic and Wegovy, also known as GLP-1 receptor agonists, work by ...

Weight loss jabs could cut the number of migraines sufferers experience by half, research suggests.. The drugs, similar to Ozempic and Wegovy, also known as GLP-1 receptor agonists, work by mimicking ...

Experts are urging Quebec to recognize obesity as a disease and cover Ozempic under public health insurance, but the government is still reviewing the issue. Skip to main content Sections ...

Ozempic is approved in Canada as a treatment for type 2 diabetes, though it has garnered headlines for its off-label use as a weight-loss drug.

Blockbuster weight-loss shots like Ozempic, Wegovy and Victoza may have an unexpected side effect impacting as many as 47million Americans, a new study from researchers in Italy found.

The mass promotion of Ozempic and its sister drugs is feeding into a harmful “diet culture” and weight shaming in Canada, some eating-disorders specialists say.

A one-off weight-loss treatment that has been around since the 1950s is far superior than drugs like Ozempic when it comes to shifting pounds, a shock study from New York City researchers reveals.